Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » PMI Biopharma, Nashville Biosciences Form Drug Development Services Alliance

PMI Biopharma, Nashville Biosciences Form Drug Development Services Alliance

Mar 06, 2020
|
staff reporter

NEW YORK — PMI Biopharma Solutions has partnered Nashville Biosciences to offer drug discovery and development services, the companies said on Friday.

Under the terms of the deal, the companies will offer Nashville Biosciences' genomic data and in silico technologies with PMI's lab and research services as a combined package for drug target identification and validation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Teasing Out How Infections Spread

The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.

How Far the Butterfly Flies

Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.

Fast COVID-19 Testing for UK

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

PLOS Papers on Mycetoma Molecular Epidemiology, Campylobacter in Retail Meat, More

In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.

Aug
19
Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Aug
24
Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

Sponsored by
Genecentric

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Sep
03
Featured Webinar

Implementation of Preemptive PGx Screening in a World-Class Personalized Medicine Program

Sponsored by
Illumina

This webinar will provide an overview of how the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado implemented a preemptive pharmacogenomic screening program via a large-scale research biobank and a robust biocomputing system.

Sep
10
Featured Webinar

Development of RNA-Based Predictive Response Signatures as Companion Diagnostics

Sponsored by
Genecentric

This webinar, Part 2 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will focus on the development of RNA-based companion diagnostics for oncology.

What's Popular?

In Informatics

  1. Double-Barcoded Single-Cell Library Prep Solves Index-Hopping Issues, Lowers Sequencing Costs

    Premium

  2. Sema4 Raises $121M in Series C Financing Round

  3. OncoDNA to Widen Cancer Analytics Offering, Biopharma Reach With IntegraGen Acquisition

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.